Therapeutic Efficacy of Polymeric Biomaterials in Treating Diabetic Wounds—An Upcoming Wound Healing Technology

Abstract

Diabetic wounds are one of the serious, non-healing, chronic health issues faced by individuals suffering from diabetic mellitus. The distinct phases of wound healing are either prolonged or obstructed, resulting in the improper healing of diabetic wounds. These injuries require persistent wound care and appropriate treatment to prevent deleterious effects such as lower limb amputation. Although there are several treatment strategies, diabetic wounds continue to be a major threat for healthcare professionals and patients. The different types of diabetic wound dressings that are currently used differ in their properties of absorbing wound exudates and may also cause maceration to surrounding tissues. Current research is focused on developing novel wound dressings incorporated with biological agents that aid in a faster rate of wound closure. An ideal wound dressing material must absorb wound exudates, aid in the appropriate exchange of gas, and protect from microbial infections. It must support the synthesis of biochemical mediators such as cytokines, and growth factors that are crucial for faster healing of wounds. This review highlights the recent advances in polymeric biomaterial-based wound dressings, novel therapeutic regimes, and their efficacy in treating diabetic wounds. The role of polymeric wound dressings loaded with bioactive compounds, and their in vitro and in vivo performance in diabetic wound treatment are also reviewed.

1. Introduction

Diabetes is a metabolic disorder that ranks as one of the top ten reasons for death among the global population. The International Diabetes Federation (IDF) has reported 463 million diabetic cases in 2019, and this count is suspected to grow to 578 million in 2030 [1,2]. Diabetes mellitus (DM) occurs when the pancreas fails to secrete the necessary amount of insulin required to maintain a normal blood sugar level in the human body. A drastic rise in blood sugar level impairs the process of wound healing, and results in chronic non-healing wounds, which may lead to hospitalization or lower extremity amputation [3]. In diabetic patients, the different phases of wound healing are hindered by various factors such as stalled expression of growth factors, metabolic insufficiency, and reduced physiological response, which prolong the time required for wound recovery [1,3] Diabetes is also connected with different types of illnesses such as chronic kidney failure, cardiovascular disease, stroke, and peripheral neuropathy [4]. Moreover, changes in motor and sympathetic functions may result in physical deformation of the feet due to extreme skin dehydration and wound formation [1]. A recent report states that almost 50 to 70% of all limb amputations are due to diabetes, and one leg is removed every thirty seconds among patients suffering from diabetes [3,5]. The management of diabetic wounds using polymer-based dressing materials has gained a lot of attention among clinicians due to their beneficial properties such as significant antibacterial, mechanical, and wound healing properties [3]. This review highlights the recent advancements in natural and synthetic polymer-based biomaterials for treating diabetic wounds.

2. Wound Healing—Physiology

Wound healing is an intricate biological process that occurs when there is a loss of integrity in skin or body tissues [6]. Wound healing requires the involvement of different types of cells, growth factors, enzymes, and various components of the extracellular matrix for repairing and restoring damaged tissues and organs [3]. It occurs in four distinct stages: haemostasis, inflammation, proliferation, and remodelling (Figure 1).

These four phases must proceed in an ordered fashion to avoid interruptions or delays in wound closure [7]. Haemostasis is a process that begins immediately after an injury to stop bleeding, and results in the formation of blood clots. During this event, platelets aggregate at the wounded site owing to the interaction with proteins such as collagen and fibronectin. Soluble fibrinogen is converted into insoluble fibrin to arrest bleeding. The area surrounding the clot and damaged tissue produces growth factors and pro-inflammatory cytokines that aid in efficient wound healing. When the bleeding has stopped, the inflammatory phase is initiated, and this involves the migration of leucocytes to the injured site to eliminate debris and infectious microorganisms [8]. This phase is characterized by the sequential infiltration of distinctive kinds of cells such as macrophages, neutrophils, and lymphocytes, which protect the wounded site from infections [9,10,11]. Macrophages play a vital role in all the stages of wound healing [12,13] as they release cytokines that are responsible for inflammation, activation of leukocytes, and clearance of apoptotic cells. As soon as apoptotic cells are cleared, macrophages are transformed into a pro-regenerative state that activates fibroblasts and keratinocytes, resulting in the regeneration of tissues. The proliferative phase is overlapped with the inflammatory phase, which leads to the proliferation and migration of epithelial cells. Fibroblasts and epithelial cells perform a vital task in the formation of collagen and granulation tissue at the site of the wound. The main components of the extracellular matrix—collagen, glycosaminoglycans, and proteoglycans—are synthesized by fibroblasts, and they play a vital role in the healing of the wound. At the end of the proliferative phase, the wound healing process moves into the final remodelling phase, which is characterized by the formation of granulation tissue [9,14].

3. Wound Healing in Diabetes

The normal phases of wound healing are disrupted due to diabetes (Figure 2). Diabetic wounds (Figure 3) continue to persist in the inflammatory phase, and the development of matured granulation tissues is inhibited by the hindering of the initiation of the proliferative phase in wound healing [3,15]. Intrinsic and extrinsic factors are involved in impairing the healing of diabetic wounds. Continuous mechanical stress and recurrent trauma can further deteriorate the healing process and result in ulcer formation [16,17]. Diabetic wound healing is delayed due to various causes such as neuropathy, poor immunity, microbial infection, oxygen deficit, and minimal activity of growth factors [3,7,18]. Numerous cells such as macrophages, neutrophils, fibroblasts, lymphocytes, keratinocytes, mast cells, and endothelial cells are actively involved in the normal wound healing process. Several growth factors and cytokines are secreted by these cells, which perform a key role in accelerating wound healing. Increased blood sugar level alters macrophage polarization, which serves as one of the chief causes for impaired diabetic wound healing. Events such as continuous secretion of pro-inflammatory cytokines, reduced angiogenic response [7], decreased activity of neutrophils, macrophages, and fibroblasts, were observed in diabetic wounds [19,20]. Diabetic wounds may also result in sensory disability towards temperature, pressure, and lesions. Lack of pain and abnormal vasodilator autoregulation together aggravate the process of wound healing [3]. Diabetic wounds may limit physical movement and cause psychiatric stress and depression [15].

4. Types of Diabetic Wound Dressings

Wound dressings quicken the process of wound healing by allowing water transmission, providing a moist atmosphere, and aiding in improved granulation and re-epithelialization. They can be incorporated with therapeutic molecules or anti-microbial agents for efficient treatment of wounds [3]. The most commonly used diabetic wound care products available on the market are Comfeel, Granuflex, and Duoderm. However, serious concerns are raised about their use in treating infected wounds, as they may cause maceration to the surrounding tissues that are present around the wound. Intrasite Gel and Aquaform are two types of hydrogels that are used in wound treatment, but their use in treating diabetic foot lesions are restricted in individuals with limb ischemia [21]. Even though there are different types of commercially available diabetic wound dressings, the percentage of exudate absorption varies between them, which demands the development of new materials for treating different types of diabetic wounds. The new materials developed must hold a perfect balance between therapeutic molecules and antibiotics that are used to reduce healing time and the chance of formation of new ulcers [22].

The different forms of wound dressings (Figure 4) are as follows.

(i) Films are transparent, sticky materials that are widely used in the field of wound treatment. Their transparent nature assists in monitoring the healing of wounds without disturbing the injured site and dressing material [23]. They allow the permeation of gases including oxygen, water vapor, and carbon dioxide between the wounded site and the environment [24]. Film-based dressing materials have various benefits such as high flexibility and elasticity, and ease in fabricating them in the desired size and shape based on the application [25].

(ii) Hydrogels are commonly used in tissue engineering and wound recovery. They are formulated by the physical or chemical cross-linking of natural or synthetic polymers. Due to their three-dimensional polymeric network, they have the ability to absorb a high quantity of water molecules when compared with their dry weight. This property makes them superior among all wound dressing materials as they can retain excessive moisture content at the wounded site [26]. They can be fabricated in various forms and sizes, and loaded with anti-microbial substances, cells, and growth factors for reducing the time required for wound closure [27]. The ability of hydrogels to maintain a moist milieu helps in promoting granulation and re-epithelization, which, in turn, results in the regeneration of tissues.

(iii) Nanofibrous dressings are a group of nanofibers with sizes ranging from nanometres (nm) to micrometers (μm) [28]. Various strategies are employed to fabricate nanofibers, but the electrospinning technique is one of the most extensively utilized methods due to its enormous merits such as cost-effectiveness, ease, versatility, control of porosity, and tuning of mechanical properties of nanofibers. Once applied on the wound, the nanofibers can be removed easily without causing any damage to the applied site [29,30,31]. They can be loaded with various bioactive molecules for treating non-healing wounds [32]. Nanofibers have the ability to imitate the native extracellular matrix. They also offer an appropriate environment for cell proliferation and adhesion for rapid healing of wounds [33].

(iv) Foam is a type of wound dressing material that is composed of both hydrophilic and hydrophobic foam with bioadhesive boundaries [34]. The hydrophobic portion prevents unnecessary entry of liquids into the wound bed but permits gaseous exchange and water vapor permeation. The advantages of using a foam-based wound dressing are that they can maintain appropriate moisture content and absorb excess volume of wound exudates [35]. Based on the thickness of the wound, foam has the ability to absorb different amounts of wound exudates [36]. However, foams are inappropriate for dry wounds with fewer exudates [37].

(v) Wafer-based wound dressings are extremely porous freeze-dried polymers that have similar characteristics to those of foams. Wafers absorb the exudate of a wound and transform it into a gel or viscous solution that provides a moist atmosphere [38]. A few polymers including xanthan gum and sodium alginate have been used for the fabrication of wafers for biomedical applications [39]. The wound exudate-absorbing property of wafers helps in reducing fluid collection and microbial infection, which, in turn, aids in the quick recovery of wounds.

(vi) Sponges are soft and flexible with interconnected pores. Due to their porous nature, they have excellent swelling ability, which is an ideal feature of a wound dressing material [40]. Different kinds of sponges have been fabricated with different types of polymers for delivering therapeutic molecules for the efficient treatment of diabetic wounds. Sponges have been proven to help in cell migration and prevent microbial infection at the wound site [3]. Due to the presence of interconnected pores, sponges enhance the migration of fibroblasts, which results in faster closure of wounds.

5. Polymeric Biomaterials

Although there have been numerous advancements in the area of wound healing, the treatment of chronic wounds continues to be a major problem in patients suffering from diabetic foot ulcers and other major injuries [41]. An ideal wound dressing material must possess special features such as absorbing wound exudates, aiding in appropriate exchange of gas, and protecting from microbial infections. They must also support in the synthesis of biochemical mediators such as cytokines and growth factors that are essential for the proper healing of wounds [42]. Bioactive compounds extracted from natural sources have been investigated to understand their role in accelerating the process of healing diabetic wounds. The study of natural materials in the form of wound dressing has gained special attention because of their potency in inducing the formation of new tissues. Synthetic polymers are also extensively used in treating diabetic wounds as they exhibit excellent mechanical, bioinert, and biocompatible characteristics. Both natural and synthetic polymeric biomaterials are considered as satisfactory wound dressings due to their exceptional properties such as increased wound healing efficacy, less/no immunogenicity, good mechanical strength, and biocompatibility. Table 1 shows the different types of wound dressing materials prepared using both natural and synthetic polymers. Herein, we discuss the various wound dressing polymeric biomaterials that are used for treating diabetic wounds.

5.1. Natural Polymers

Natural biomaterials are considered to be suitable candidates for preparing wound dressing material due to their exceptional properties such as less/no immunogenicity and good biocompatibility. They also serve as satisfactory matrices for cells that play imperative roles in the process of wound healing. Some of the widely accepted natural products extracted from natural sources that are widely used as wound dressing material are collagen, gelatin, fibrin and silk proteins.

5.1.1. Collagen

Collagen provides integrity to human skin and serves as a principal component of the extracellular matrix (ECM) [96]. It is abundantly present in bones, ligaments, and tendons. It has distinctive properties such as excellent biocompatibility, thermal stability, mechanical strength, and low immunogenicity [97,98]. Collagen plays a vital role in haemostasis as it interacts with the platelets that are deposited at the site of wound through chemotaxis [99]. It mediates various pro-regenerative physiological interactions that are responsible for wound healing. Collagen is extensively used as a matrix for wound treatment and tissue regeneration. Collagen is isolated from different types of sources such as bovine, equine and, porcine tissues [100,101]. Although there are 29 types of collagens, type 1 collagen is widely available and can be extracted easily from mammalian connective tissues [102,103]. The most commonly used type 1 collagen is isolated from the tendons of rat tails [104,105]. Bovine collagen is extracted from several tissues such as bone, skin, and the Achilles tendon [106,107]. Collagen is formulated in the form of scaffolds with varying concentrations and pore sizes. These scaffolds can absorb wound exudates, attach onto the wound bed, and provide moist environment [108].

Collagen-based scaffolds (Figure 5) are commonly used as a wound dressing material for treating skin burns, foot ulcers, and pressure sores [109]. In certain cases, collagen is combined with other sources such as fibronectin or elastin to improve the fluid-binding property of the scaffolds [110,111]. Collagen is also fabricated in the form of implants that can be used as a support for delivering keratinocytes for skin regeneration [112,113,114]. After implantation, collagen scaffolds are infiltrated by connective tissues that are composed of glycosaminoglycan, new collagen, fibroblasts, and macrophages. Based on the cross-linking percentage, collagen scaffolds are degraded into small peptides within a few weeks of implantation, and replaced by native collagen that is synthesized by fibroblasts [115]. Apligraf^®—the first tissue-engineered wound dressing material that was approved for treating diabetic ulcers—was made up of two-layered collagen hydrogels loaded with human keratinocytes and fibroblasts [116]. Subsequently, several modifications were carried out by altering the concentration of collagen to improve the mechanical strength of Apligraf^®. When collagen concentration was increased, there was a significant rise in the proliferation of fibroblasts and stimulation of keratinocyte growth factor, which lead to the faster healing of wounds [117]. At present, collagen-based wound dressing materials are widely accepted in managing full-thickness wounds and skin burns. It is also possible to enhance the activity of collagen by combining it with bioactive therapeutic agents and antimicrobial compounds substances that accelerate the rate of wound closure [118]. Type 1 collagen has the ability to draw growth factors toward the wounded area and quicken the healing and regeneration of damaged tissues [98]. However, in the case of diabetic wounds or diabetic foot ulcers, the epidermis becomes ulcerous, resulting in the deficiency of type 1 collagen. This further delays the proliferation and migration of fibroblasts, which, in turn, prolongs the time required for wound healing [119]. Lee et al. determined the ability of collagen (colladerm) wound dressing in treating diabetic foot ulcers. When patients were treated with collagen dressing every 2–3 days for up to 3 weeks, a significant decrease in the wound area with 73.7% healing of the diabetic wound ulcer was observed. The results demonstrated the safety and efficacy of collagen dressing in faster healing of diabetic foot ulcers [120]. Hauck et al. demonstrated the possible use of hyaluronan/collagen hydrogels loaded with high-sulphated hyaluronan in treating dermal wounds in diabetic mice models. The hydrogel enhanced the healing rate of damaged tissues with decreased inflammation, improved vascularization, and increased pro-regenerative macrophage activation, and hastened the formation of new tissues for wound closure [121]. Shagdarova et al. prepared hydrogels using chitosan, collagen, and silver nanoparticles for treating diabetic injuries/wounds. The hydrogels had a fibrous porous structure with a better swelling ratio. When applied onto diabetic wounds, the hydrogels elevated the expression of genes such as vascular endothelial growth factor, Interleukin 1b, tissue inhibitor of metalloproteinases-1, and transforming growth factor beta 1 [122].

5.1.2. Gelatin

Gelatin is a natural polymer that is obtained from the partial hydrolysis of collagen [123]. Due to its salient features such as availability, biodegradability, biocompatibility, cell-interactivity, and non-toxicity, gelatin is commonly used in the field of biomedicine [124]. When used as a scaffold, gelatin has the ability to absorb water molecules, making it an appropriate candidate for wound dressing material. The main drawback associated with gelatin is its poor stability and mechanical strength. Therefore, to increase its mechanical stability, gelatin is cross-linked with agents such as glutaraldehyde, fructose, dextran, genipin, formaldehyde, and carbodiimides [125]. Samadian et al. developed berberine-loaded cellulose acetate/gelatin electrospun mats as wound dressing for treating diabetic foot ulcers. The fibres had an average diameter of 502 ± 150 nm, and demonstrated antibacterial behaviour against Staphylococcus aureus and Pseudomonas aeruginosa. The electrospun mats exhibited suitable tensile strength and water uptake potency required for a wound dressing material. A haemolytic assay performed using red blood cells showed that the percentage of haemolysis was significantly low for berberine-loaded cellulose acetate/gelatin electrospun mats when compared with the positive control—water [126]. Yu et al. prepared a paeoniflorin-sodium alginate (SA)-gelatin skin scaffold with a mesh-like structure with uniform pore distribution for treating diabetic wounds. Animal models showed improved deposition of collagen with microvascular regeneration when treated with the skin scaffold, thereby proving their possible use in the field of diabetic wound treatment [127]. Sadeghi et al. prepared biodegradable scaffolds using gelatin and sulphated alginate as skin replacements to accelerate the healing of diabetic wounds. The carbodiimide mode of cross-linking followed by lyophilization was carried out to prepare the scaffolds. Cell culture analysis proved the non-toxicity of the scaffolds, with enhanced cell growth when the quantity of sulphated alginate was increased in the scaffold. Diabetic animal models proved the ability of the scaffold to cure wounds by providing the required environment for faster healing of wounds [128].

5.1.3. Fibrin

Fibrin is obtained from fibrinogen, which is converted in response to tissue injury. It acts as a mesh and forms blood clots to prevent bleeding. Fibrin is extensively used for clinical applications, in the form of sealants and haemostatic agents [129]. When used in the form of scaffolds, it has the ability to deliver inflammatory cells and growth factors that are necessary for wound repair and tissue regeneration [130].

Fibrin serves as a substrate for different types of cells such as platelets, fibroblasts, endothelial cells, and macrophages. It triggers the process of cellular proliferation and new blood vessel formation, thereby leading to efficient healing of wounds. Fibrin can be formulated in different structures such as nanoparticles, hydrogels, scaffolds and films. Fibrin-based cell delivery is widely accepted for treating dermal wounds, as it stimulates neovascularization and the rejuvenation of skin cells [131]. For treating skin burns, fibrin-based hydrogels/films are utilized for the transplantation of keratinocytes to induce fibroblast formation and re-epithelization. Fibrin scaffolds loaded with vascular endothelial factor and fibroblast growth factor enhanced re-epithelization, collagen deposition, and accelerated wound closure in mice with diabetic wounds [132]. Fibrin as a scaffold has the ability to mimic the extracellular matrix and enhance the interaction of cells responsible for tissue regeneration [133,134]. Geer et al. studied the re-epithelializing performance of fibrin using human keratinocytes under in vitro conditions [135]. Falanga et al. demonstrated that when bone marrow-derived mesenchymal stem cells (Figure 6) were entrapped within fibrin, they reduced the time taken for wound closure in acute and chronic wounds [136]. When bone marrow nuclear cells were mixed and injected along with fibrin gel to treat infarcted myocardium, it resulted in neovascularization and increased tissue regeneration. Fibrin-based formulations are highly efficient in curing diabetic wounds. Crisci et al. investigated the efficacy of fibrin rich in leukocytes and platelets (FLP) in treating osteomyelitis ulcers in diabetic feet. FLP was collected from diabetic individuals suffering from osteomyelitis and skin lesions for a minimum period of 180 days. Surgical debridement was carried out to deliver FLP directly into skin lesions of patients, and the development of lesions was assessed periodically. The study report (Figure 7) stated that FLP treatment settled down skin lesions with no indication of microbial infection [137].

Losi et al. employed electrospinning and spray phase-inversion procedures to synthesize bilayered fibrin/poly(ether)urethane scaffolds rich in platelet lysate for treating diabetic wounds. Cell culture experiments performed using L929 mouse fibroblasts proved that the efficacy of two important growth factors—platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF), which play a crucial role in healing chronic wounds—was retained in the electrospun scaffolds. An in vitro release study of PDGF and VEGF from the synthesized scaffolds demonstrated an initial burst release of growth factors within 24 h of study, followed by sustained release for one week. When applied onto full-thickness wounds in diabetic animal models, a significant improvement in wound closure within 2 weeks of treatment was observed. Moreover, improved re-epithelialization and collagen deposition were also witnessed in wounds treated with the scaffolds, thereby proving their potency in healing diabetic wounds/ulcers [138]. Poly(ether)urethane-polydimethylsiloxane/fibrin-based scaffolds containing poly(lactic-co-glycolic acid) nanoparticles loaded with recombinant human vascular endothelial growth factor and basic fibroblast growth factor were fabricated by Losi et al. with the intention of triggering cellular proliferation and accelerating the process of wound healing in genetically diabetic mice. The presence of growth factors in the scaffolds quickened the rate of closure of full-thickness skin wounds on day 15 in diabetic mice. Histological analysis showed extensive re-epithelialization, with increased granulation tissue formation/maturity and collagen deposition, thereby elucidating the efficiency of the prepared scaffolds in treating diabetic wounds [133].

5.1.4. Silk Proteins

Silk cocoons are discarded as waste by the silk industry, but they can be used as valuable resources for fabricating wound dressings that can aid in faster healing of wounds. Silk-based biomaterials are extensively used in the field of medicine due to their excellent biocompatibility and biodegradability. The FDA approved product silk voice is a type of scaffold, prepared using reconstituted or solubilized silk protein [139]. Silk protein has the capability to induce cell migration and proliferation, and attract cells such as keratinocytes to the wounded site, thereby accelerating the process of wound healing [140]. Two different types of proteins—silk fibroin and silk sericin—are isolated from the cocoons of silkworms (Figure 8). They are widely used in biomedical applications due to their lower immunogenicity, biodegradability, biocompatibility, moisture absorption, UV resistance, and antibacterial properties [141].

Silk proteins are fabricated in various forms such as films, nanofibers, and sponges for biomedical applications. When used as a wound dressing material, silk proteins have enhanced fibroblast adhesion and lead to faster healing of wounds [142]. The middle and posterior silk glands of silkworm Bombyx mori secretes two important proteins, silk fibroin and silk sericin, which are extensively used to accelerate the healing of wounds [143]. Silk fibroin has extraordinary thermal stability and mechanical strength when compared with polymers such as collagen and polylactic acid. In addition, the presence of an RGD peptide sequence promotes the attachment, movement, and proliferation of cells such as keratinocytes, endothelial, epithelial, and glial cells, and osteoblasts for the effective healing of wounds. Porous silk fibroin scaffolds/sponges can be prepared using different types of techniques such as lyophilization, gas forming, and freeze-drying/foaming methods [144]. Liu et al. prepared silk fibroin scaffolds incorporated with neurotensin-loaded gelatin microspheres as a novel therapeutic regime for healing diabetic foot ulcers in diabetic rat models. Macroscopic evaluation of wounds showed significant reduction in wound size on day 14 in the experimental group. In addition, histological and immunofluorescence analyses demonstrated the accumulation of fibroblasts with a substantial expression of collagen at the site of the wound. The prepared scaffolds had a good porosity of approximately 85%, with an average pore size of 40–80 μm [145]. Guan et al. fabricated microneedle patches with multiple features such as anti-microbial, anti-oxidant, and pro-angiogenic properties for targeting diabetic lesions/wounds. The microneedles were constructed using silk fibroin methacryloyl with tremendous biocompatibility and mechanical stability. Two different bioactive molecules—VEGF and Prussian blue nanozymes—were loaded on the tip of microneedles with polymyxin—an anti-bacterial agent—at the base layer of the microneedle patches. The patches played a significant role in treating diabetic skin wounds [146]. Xu et al. prepared electrospun Huangbai liniment-loaded silk fibroin/poly-(L-lactide-co-caprolactone) nanofibers for treating diabetic wounds. The fibres were smooth, without any bead formation when viewed under a scanning electron microscope. The nanofibers exhibited antibacterial activity against Escherichia coli and Staphylococcus aureus. Cell culture experiments showed enhanced adhesion and proliferation of NIH-3T3 cells when cultured on the nanofibers. Animal experiments using a diabetic mice model proved that the nanofibers had the ability to elevate the synthesis of collagen and expression of the TGF-β signalling pathway, which, in turn, promoted efficient healing of diabetic wounds [147]. Silk sericin is a globular protein with significant features such as non-immunogenicity, good biocompatibility, biodegradability, anti-oxidant properties, and regenerative potency. It serves as a promising biomaterial in the field of medicine. Silk sericin-based hydrogels were prepared using horseradish peroxidase (HRP) and hydrogen peroxide cross-linking methods. A chorioallantoic membrane assay performed using chick embryos showed a minimal rise in the number of new blood vessels in the test group when compared with that of the control. The hydrogel showed collagen deposition and mild induction of superoxide dismutase and catalase in diabetic wounds treated with hydrogel in the mouse model [148]. Samad et al. formulated carboxymethyl cellulose/sericin hydrogels for diabetic wound treatment. The hydrogels had porous morphology, excessive swelling efficacy, and anti-microbial properties. When applied on to full-thickness excision wounds in diabetic rats, the upregulation of collagen deposition and downregulation of pro-inflammatory markers was witnessed, which led to the healing of wounds without any insulin treatment [149].

5.2. Synthetic Polymers for Diabetic Wounds

Synthetic polymers are used in combination with natural polymers for treating diabetic wounds because they exhibit excellent mechanical properties. They are used for tissue engineering applications owing to their inert and biocompatible characteristics. Synthetic polymers such as polycaprolactone (PCL), poly(vinyl alcohol) (PVA), Poly(2-hydroxyethyl methacrylate) (pHEMA), polylactide (PLA), and polyglycolic acid (PGA) have been used as scaffolds in tissue engineering and wound healing applications along with natural polymers [3,150,151].

5.2.1. Polycaprolactone (PCL)

PCL is a hydrophobic polymer that has a great degradation rate and excellent bioactivity. It is a linear aliphatic semicrystalline polymer. PCL polymer can be modified by changing the molecular weight, crystallinity, or structure using polyethylene glycol and hydrophobic ceramics, or by creating copolymers with PLA and PGA. PCL exhibits reduced cellular attachment owing to its hydrophobicity, which can be altered by modifying its surface with other biomaterials [152]. An organic and inorganic composite scaffold containing two-dimensional nanovermiculite and PCL electrospun fibres for treating diabetic wounds were prepared by Huang et al. The results show that polycaprolactone electrospun fibres with two-dimensional vermiculite nanosheets could significantly improve neo-vascularization, re-epithelialization, and collagen formation in the diabetic wound bed [153]. Amine-terminated block copolymers containing PCL and polyethylene glycol and PCL were electrospun using electrospinning technique by Choi et al. The human epidermal growth factors (EGF) were immobilized on the surface of the nanofibers. Dorsal wounds were created in diabetic animals in order to study the wound healing efficacy of the prepared wound dressing material. Immunohistochemical studies showed that the EGF receptor were highly expressed in the nanofiber-treated groups. The results showed that the prepared nanofibers could be a potential material for treating diabetic wounds [47]. Merrell et al. used PCL nanofibers as drug delivery vehicles. He prepared PCL nanofibers loaded with curcumin and used them as a diabetic wound dressing material. In total, 70% of human foreskin fibroblast cells (HFF-1) cells were viable when treated with the prepared nanofibers. A streptozocin-induced diabetic mouse model were used for the in vivo study, which showed an increased rate of wound closure in animals treated with the nanofibers. The study proved that the prepared nanofibers are bioactive, with anti-inflammatory and antioxidant properties [53]. Lv et al. prepared a PCL/gelatin nanofiber composite scaffold containing silicate-based ceramic particles (Nagelschmidtite, NAGEL, Ca₇P₂Si₂O₁₆) through the co-electrospinning technique for diabetic wound healing (Figure 9). In vivo studies revealed that these nanofiber composite scaffolds promoted angiogenesis, the deposition of collagen, and re-epithelialization at the wounded site in the diabetic mice. The results suggested that the release of Si ions and the structure of nanofibrous scaffolds have the potential for diabetic wound healing, and pave the way for biomaterials used in the field of both wound healing and tissue engineering applications [154].

5.2.2. Poly(vinyl alcohol) (PVA)

PVA is an excellent biocompatible synthetic polymer produced by the hydrolysis of vinyl acetate. It is one of the US Food and Drug Administration (FDA)-approved synthetic polymeric materials. The value of PVA is growing at an enormous rate, as it is utilized for biomedical applications owing to desirable characteristics such as non-carcinogenic, non-toxic, bio-adhesive, and swelling behaviours. PVA has been potentially used in soft eye lenses, cartilages, and eye drops, etc. PVA can be fabricated in different forms such as fibres, gel, and film that support in aiding the adhesion and proliferation of cells [155]. Huang et al. fabricated electrospun brown alga-derived polysaccharide and PVA nanofibers for skin repair in diabetic mice. Brown alga-derived polysaccharide is a sea mustard found in marine areas. The result suggested that the prepared nanofibers decreased inflammation and stimulated angiogenesis at the wound site of diabetic mice [156]. Lin et al. synthesized PVA/cobalt-substituted hydroxyapatite nanocomposites as a wound dressing material for diabetic foot ulcer treatment. The nanocomposites were prepared using solvent casting method. The result showed that the prepared nanocomposites had high mechanical properties and excellent bioactivity. The nanocomposites discharged a small number of cobalt ions into the cell-cultured medium, which showed better cell growth. The prepared nanocomposites could be a potential wound dressing material for diabetic foot ulcer treatment [157]. Zhu et al. fabricated PVA hydrogel loaded with fibroblast growth factor 21 and metformin for diabetic wound healing. The fabricated hydrogel were injectable, adhesive and ROS scavenging abilities. In vivo results showed the formation of blood vessels with faster healing of diabetic wounds [158]. Wang et al. prepared PVA/chitosan nanocomposite hydrogels incorporated with Tibetan eighteen-flavour dangshen pills (TEP) for treating chronic diabetic wounds. TEP is a traditional Tibetan medicine used to treat skin diseases with analgesic, anti-inflammatory, and healing properties. This hydrogel were treated with L939 cells, which showed no cytotoxic effect and demonstrated that the new formulation can be used for treating diabetic wounds with the help of traditional medicine [159]. Cellulose and PVA-based films incorporated with Vitamin C and/or propolis for faster diabetic wound healing were created by Voss et al. Cellulose-PVA/Vitamin C and Cellulose-PVA/Vitamin C/Propolis films were prepared in order to analyse the release of Vitamin C in a precise manner. When Cellulose-PVA/Vitamin C/Propolis were used in an STZ-induced diabetic animal model, it showed faster wound closure. Histopathological analysis showed better results when treated with Cellulose-PVA/Vitamin-C/Propolis. The results suggest that the prepared PVA-based film could be a potential treatment procedure for faster wound healing (Figure 10) [74].

Ahmed et al. fabricated chitosan, PVA, and zinc oxide nanofibrous mats using electrospinning technique for faster healing of diabetic wounds. The compounds chitosan and PVA have wound-healing properties, and zinc oxide has excellent antibacterial activity. The result showed that these nanofiber mats exhibit efficient antibacterial and antioxidant properties. In vivo analysis showed that there was faster healing of diabetic wounds in groups treated with nanofiber mats [43]. Kim et al. developed a new film-forming hydrogel including PVA, polyvinylpyrrolidone, and propylene glycol incorporated with sodium fusidate for wound healing applications. The film showed excellent elasticity and flexibility, and could be an effective pharmaceutical product for wound treatment [69].

5.2.3. Poly(2-Hydroxyethyl Methacrylate) (pHEMA)

pHEMA is a hydrophilic, non-biodegradable, and biocompatible polymer that is widely used for different types of wound healing, bone regeneration, and cancer treatment. pHEMA-based biomaterial gained lot of attention in wound treatment and ocular therapy due to its excellent biocompatible and minimal thrombogenic properties. Due to its transparent nature, it facilitates the tracking of wound recovery when used as wound dressing material. Bacterial cellulose pHEMA and silver were combined as a multifunctional wound dressing material with efficient antimicrobial properties [160].

5.2.4. Polylactide (PLA) and Polyglycolic Acid (PGA)

PGA and PLA are extensively suitable for the fabrication of scaffolds. These two synthetic polymers serve as a suitable platform for tissue construction. Moreover, these polymers have been used as implantable materials in the field of medicine. Polyglycolic acid is the first synthetic polymer utilized in the form of suture under the name of “Dexon”. At the site of the wound, PLGA and PLA stimulate the supply of lactic acid, and help in inducing angiogenesis and quickening the process of wound healing [155]. Khazaeli et al. prepared PLA/chitosan nanoscaffolds using the microwave-assisted electrospinning technique loaded with cod liver oil for diabetic wound healing. The results showed that the groups treated with nanoscaffolds exhibited wound recovery within 14 days of treatment [161]. Zheng et al. fabricated polylactic co-glycolic acid/cellulose nanocrystal nanofibers loaded with neurotensin to study their therapeutic potency in treating diabetic wounds. The prepared nanofibers were applied on wounds in diabetic mice, which showed a slow release of neurotensin for 2 weeks. The results suggested that the prepared nanofibers effectively stimulate the regeneration of tissues for diabetic foot ulcer treatment [59]. Zha et al. prepared polyglycolic acid/silk fibroin nanofibrous scaffolds incorporated with deferoxamine for diabetic wound healing application. The prepared nanofibrous scaffold had a porous three-dimensional nanofibrous structure and exhibited good mechanical strength, biodegradability, and biocompatibility, which could promote cell adhesion, growth, and migration. The in vivo results showed that the prepared nanofibrous scaffold accelerated the wound healing rate in treated groups [162].

6. Future Perspectives and Conclusions

To date, there are numerous polymer-based wound dressings for treating and managing diabetic wounds/foot ulcers. These dressings differ in their porosity, mechanical strength, swelling, and moisture absorption properties. They aid in cellular adhesion, proliferation, and migration without causing any cytotoxicity or immunotoxicity. Wound dressings protect wounds from microbial infections and physical damage. The efficacy of the polymeric biomaterials can be improved by loading therapeutic molecules, growth factors, and anti-microbial agents that could accelerate the process of wound closure by triggering collagen deposition and vascularization. The implantation of the dressing material exactly at the site of the wound is a challenging procedure, as it requires appropriate coordination between the scientist and physician. The method employed to synthesize scaffolds is also crucial as it plays a vital role in determining the quality and performance of the wound dressings. In addition, the fabrication technique may involve costly sophisticated instruments, which may further increase the cost of treatment. Therefore, it is important to recognize the issues that affect clinical translation, and pursue alternatives that can overcome the current problems.

Further, research in the field of 3D printing and tissue engineering can improve the potency of polymeric wound dressings for efficient diabetic wound treatment. Wound dressing materials that are 3D printed can serve as a unique platform and can be incorporated with different types of bioactive compounds and antimicrobial agents that can speed up the rate of wound healing. The use of 3D printing can overcome the disadvantages associated with the conventional techniques, and is highly reliable and low-cost. Additionally, the combination of biomarkers and nanoparticles that can be used to monitor wound recovery can be loaded with the wound dressing materials for efficient diabetic wound treatment.

Competing interests

Conflicts of InterestThe authors declare no conflict of interest.

References

1. Patel S., Srivastava S., Singh M.R., Singh D.. Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomed. Pharmacother.. 2019 doi:10.1016/j.biopha.2019.108615 PubMed
2. Selle J.J., Aminuddin A., Chellappan K.. Benefit of Foot Thermogram Analysis in the Treatment of Diabetic Foot Ulcer: A Systematic Review. Biomed. Res. Ther.. 2022 doi:10.15419/bmrat.v9i5.737
3. Alven S., Peter S., Mbese Z., Aderibigbe B.A.. Polymer-Based Wound Dressing Materials Loaded with Bioactive Agents: Potential Materials for the Treatment of Diabetic Wounds. Polymers. 2022 doi:10.3390/polym14040724 PubMed
4. Okonkwo U.A., DiPietro L.A.. Diabetes and Wound Angiogenesis. Int. J. Mol. Sci.. 2017 doi:10.3390/ijms18071419 PubMed
5. Spampinato S.F., Caruso G.I., De Pasquale R., Sortino M.A., Merlo S.. The Treatment of Impaired Wound Healing in Diabetes: Looking among Old Drugs. Pharmaceuticals. 2020 doi:10.3390/ph13040060 PubMed
6. Singh S., Young A., McNaught C.-E.. The physiology of wound healing. Surgery. 2017 doi:10.1016/j.mpsur.2017.06.004
7. Guo S., DiPietro L.A.. Factors Affecting Wound Healing. J. Dent. Res.. 2010 doi:10.1177/0022034509359125 PubMed
8. Subramaniam T., Fauzi M., Lokanathan Y., Law J.. The Role of Calcium in Wound Healing. Int. J. Mol. Sci.. 2021 doi:10.3390/ijms22126486 PubMed
9. Gosain A., DiPietro L.A.. Aging and Wound Healing. World J. Surg.. 2004 doi:10.1007/s00268-003-7397-6 PubMed
10. Broughton G., Janis J.E., Attinger C.E.. The Basic Science of Wound Healing. Plast. Reconstr. Surg.. 2006 doi:10.1097/01.prs.0000225430.42531.c2 PubMed
11. Keylock K.T., Vieira-Potter V., Wallig M.A., DiPietro L.A., Schrementi M., Woods J.A.. Exercise accelerates cutaneous wound healing and decreases wound inflammation in aged mice. Am. J. Physiol. Integr. Comp. Physiol.. 2008 doi:10.1152/ajpregu.00177.2007 PubMed
12. Krzyszczyk P., Schloss R., Palmer A., Berthiaume F.. The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes. Front. Physiol.. 2018 doi:10.3389/fphys.2018.00419 PubMed
13. Mosser D.M., Edwards J.P.. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol.. 2008 doi:10.1038/nri2448 PubMed
14. Campos A.C., Groth A.K., Branco A.B.. Assessment and nutritional aspects of wound healing. Curr. Opin. Clin. Nutr. Metab. Care. 2008 doi:10.1097/MCO.0b013e3282fbd35a PubMed
15. Oro F.B., Sikka R.S., Wolters B., Graver R., Boyd J.L., Nelson B.J. et al. Autograft Versus Allograft: An Economic Cost Comparison of Anterior Cruciate Ligament Reconstruction. Arthrosc. J. Arthrosc. Relat. Surg.. 2011 doi:10.1016/j.arthro.2011.04.008 PubMed
16. Flynn M., Tooke J.. Aetiology of Diabetic Foot Ulceration: A Role for the Microcirculation?. Diabet. Med.. 1992 doi:10.1111/j.1464-5491.1992.tb01790.x PubMed
17. Tsourdi E., Barthel A., Rietzsch H., Reichel A., Bornstein S.R.. Current Aspects in the Pathophysiology and Treatment of Chronic Wounds in Diabetes Mellitus. BioMed Res. Int.. 2013 doi:10.1155/2013/385641 PubMed
18. Burgess J.L., Wyant W.A., Abdo Abujamra B., Kirsner R.S., Jozic I.. Diabetic Wound-Healing Science. Medicina. 2021 doi:10.3390/medicina57101072 PubMed
19. Okizaki S.-I., Ito Y., Hosono K., Oba K., Ohkubo H., Amano H. et al. Suppressed recruitment of alternatively activated macrophages reduces TGF-β1 and impairs wound healing in streptozotocin-induced diabetic mice. Biomed. Pharmacother.. 2015 doi:10.1016/j.biopha.2014.10.020 PubMed
20. Loots M.A., Kenter S.B., Au F.L., van Galen W., Middelkoop E., Bos J.D. et al. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur. J. Cell Biol.. 2002 doi:10.1078/0171-9335-00228 PubMed
21. Hilton J.R., Williams D.T., Beuker B., Miller D.R., Harding K.G.. Wound Dressings in Diabetic Foot Disease. Clin. Infect. Dis.. 2004 doi:10.1086/383270 PubMed
22. Gianino E., Miller C., Gilmore J.. Smart Wound Dressings for Diabetic Chronic Wounds. Bioengineering. 2018 doi:10.3390/bioengineering5030051 PubMed
23. Sood A., Granick M.S., Tomaselli N.L.. Wound Dressings and Comparative Effectiveness Data. Adv. Wound Care. 2014 doi:10.1089/wound.2012.0401 PubMed
24. Negut I., Grumezescu V., Grumezescu A.M.. Treatment Strategies for Infected Wounds. Molecules. 2018 doi:10.3390/molecules23092392 PubMed
25. Gupta B., Agarwal R., Alam M.. Textile-Based Smart Wound Dressings. Indian J. Fibre Text. Res.. 2010
26. Tavakoli S., Klar A.S.. Advanced Hydrogels as Wound Dressings. Biomolecules. 2020 doi:10.3390/biom10081169 PubMed
27. Gupta P., Vermani K., Garg S.. Hydrogels: From controlled release to pH-responsive drug delivery. Drug Discov. Today. 2002 doi:10.1016/S1359-6446(02)02255-9 PubMed
28. Xu S.-C., Qin C.-C., Yu M., Dong R.-H., Yan X., Zhao H. et al. A battery-operated portable handheld electrospinning apparatus. Nanoscale. 2015 doi:10.1039/C5NR02922H PubMed
29. Hajilou H., Farahpour M.R., Hamishehkar H.. Polycaprolactone nanofiber coated with chitosan and Gamma oryzanol functionalized as a novel wound dressing for healing infected wounds. Int. J. Biol. Macromol.. 2020 doi:10.1016/j.ijbiomac.2020.08.079 PubMed
30. Mulholland E.J., Ali A., Robson T., Dunne N.J., McCarthy H.O.. Delivery of RALA/siFKBPL nanoparticles via electrospun bilayer nanofibers: An innovative angiogenic therapy for wound repair. J. Control. Release. 2019 doi:10.1016/j.jconrel.2019.10.050 PubMed
31. Zhao Y., Qiu Y., Wang H., Chen Y., Jin S., Chen S.. Preparation of Nanofibers with Renewable Polymers and Their Application in Wound Dressing. Int. J. Polym. Sci.. 2016 doi:10.1155/2016/4672839
32. Liu M., Duan X.P., Li Y.M., Yang D.P., Long Y.Z.. Electrospun nanofibers for wound healing. Mater. Sci. Eng. C. 2017 doi:10.1016/j.msec.2017.03.034 PubMed
33. Heydari P., Varshosaz J., Kharazi A.Z., Karbasi S.. Preparation and evaluation of poly glycerol sebacate/poly hydroxy butyrate core-shell electrospun nanofibers with sequentially release of ciprofloxacin and simvastatin in wound dressings. Polym. Adv. Technol.. 2018 doi:10.1002/pat.4286
34. Dhivya S., Padma V.V., Santhini E.. Wound dressings—A review. BioMedicine. 2015 doi:10.7603/s40681-015-0022-9 PubMed
35. Morgan D.. Wounds—What Should a Dressing Formulary Include?. Hosp. Pharm.. 2002
36. Vijayan A., Nanditha C.K., Kumar G.S.V.. ECM-mimicking nanofibrous scaffold enriched with dual growth factor carrying nanoparticles for diabetic wound healing. Nanoscale Adv.. 2021 doi:10.1039/D0NA00926A PubMed
37. Ramos-E-Silva M., de Castro M.C.R.. New dressings, including tissue-engineered living skin. Clin. Dermatol.. 2002 doi:10.1016/S0738-081X(02)00298-5 PubMed
38. Lipsky B.A., Hoey C.. Topical Antimicrobial Therapy for Treating Chronic Wounds. Clin. Infect. Dis.. 2009 doi:10.1086/644732 PubMed
39. Matthews K., Stevens H., Auffret A., Humphrey M., Eccleston G.. Formulation, stability and thermal analysis of lyophilised wound healing wafers containing an insoluble MMP-3 inhibitor and a non-ionic surfactant. Int. J. Pharm.. 2008 doi:10.1016/j.ijpharm.2007.12.043 PubMed
40. Yang X., Liu W., Xi G., Wang M., Liang B., Shi Y. et al. Fabricating antimicrobial peptide-immobilized starch sponges for hemorrhage control and antibacterial treatment. Carbohydr. Polym.. 2019 doi:10.1016/j.carbpol.2019.115012 PubMed
41. Toleubayev M., Dmitriyeva M., Kozhakhmetov S., Sabitova A.. Efficacy of erythropoietin for wound healing: A systematic review of the literature. Ann. Med. Surg.. 2021 doi:10.1016/j.amsu.2021.102287 PubMed
42. Aramwit P.. Introduction to Biomaterials for Wound Healing. Wound Healing Biomaterials. 2016
43. Ahmed R., Tariq M., Ali I., Asghar R., Khanam P.N., Augustine R. et al. Novel electrospun chitosan/polyvinyl alcohol/zinc oxide nanofibrous mats with antibacterial and antioxidant properties for diabetic wound healing. Int. J. Biol. Macromol.. 2018 doi:10.1016/j.ijbiomac.2018.08.057 PubMed
44. Cam M.E., Yildiz S., Alenezi H., Cesur S., Ozcan G.S., Erdemir G. et al. Evaluation of burst release and sustained release of pioglitazone-loaded fibrous mats on diabetic wound healing: An in vitro and in vivo comparison study. J. R. Soc. Interface. 2020 doi:10.1098/rsif.2019.0712 PubMed
45. Almasian A., Najafi F., Eftekhari M., Ardekani M.R.S., Sharifzadeh M., Khanavi M.. Polyurethane/carboxymethylcellulose nanofibers containing Malva sylvestris extract for healing diabetic wounds: Preparation, characterization, in vitro and in vivo studies. Mater. Sci. Eng. C. 2020 doi:10.1016/j.msec.2020.111039 PubMed
46. Chen X., Zhou W., Zha K., Liu G., Yang S., Ye S. et al. Treatment of chronic ulcer in diabetic rats with self assembling nanofiber gel encapsulated-polydeoxyribonucleotide. Am. J. Transl. Res.. 2016 PubMed
47. Choi J.S., Leong K.W., Yoo H.S.. In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials. 2008 doi:10.1016/j.biomaterials.2007.10.012 PubMed
48. Cui S., Sun X., Li K., Gou D., Zhou Y., Hu J. et al. Polylactide nanofibers delivering doxycycline for chronic wound treatment. Mater. Sci. Eng. C. 2019 doi:10.1016/j.msec.2019.109745 PubMed
49. Grip J., Engstad R.E., Skjæveland I., Škalko-Basnet N., Isaksson J., Basnet P. et al. Beta-glucan-loaded nanofiber dressing improves wound healing in diabetic mice. Eur. J. Pharm. Sci.. 2018 doi:10.1016/j.ejps.2018.05.031 PubMed
50. Kanji S., Das M., Joseph M., Aggarwal R., Sharma S.M., Ostrowski M. et al. Nanofiber-expanded human CD34+ cells heal cutaneous wounds in streptozotocin-induced diabetic mice. Sci. Rep.. 2019 doi:10.1038/s41598-019-44932-7 PubMed
51. Lee C.-H., Liu K.-S., Cheng C.-W., Chan E.-C., Hung K.-C., Hsieh M.-J. et al. Codelivery of Sustainable Antimicrobial Agents and Platelet-Derived Growth Factor via Biodegradable Nanofibers for Repair of Diabetic Infectious Wounds. ACS Infect. Dis.. 2020 doi:10.1021/acsinfecdis.0c00321 PubMed
52. Lee C.-H., Hung K.-C., Hsieh M.-J., Chang S.-H., Juang J.-H., Hsieh I.-C. et al. Core-shell insulin-loaded nanofibrous scaffolds for repairing diabetic wounds. Nanomedicine. 2020 doi:10.1016/j.nano.2019.102123 PubMed
53. Merrell J.G., McLaughlin S.W., Tie L., Laurencin C.T., Chen A.F., Nair L.S.. Curcumin loaded poly (ε-caprolactone) nanofibers: Diabetic wound dressing with antioxidant and anti-inflammatory properties. Clin. Exp. Pharmacol. Physiol.. 2009 doi:10.1111/j.1440-1681.2009.05216.x PubMed
54. García A.D.P., Cassini-Vieira P., Ribeiro C.C., Jensen C.E.D.M., Barcelos L.S., Cortes M.E. et al. Efficient cutaneous wound healing using bixin-loaded PCL nanofibers in diabetic mice. J. Biomed. Mater. Res. Part B Appl. Biomater.. 2017 doi:10.1002/jbm.b.33724 PubMed
55. Ranjbar-Mohammadi M., Rabbani S., Bahrami S.H., Joghataei M., Moayer F.. Antibacterial performance and in vivo diabetic wound healing of curcumin loaded gum tragacanth/poly(ε-caprolactone) electrospun nanofibers. Mater. Sci. Eng. C. 2016 doi:10.1016/j.msec.2016.08.032 PubMed
56. Shalaby T., Fekry N.M., El Sodfy A.S., Elsheredy A., Moustafa M.E.S.S.A.. Preparation and characterisation of antibacterial silver-containing nanofibers for wound healing in diabetic mice. Int. J. Nanoparticles. 2015 doi:10.1504/IJNP.2015.070346
57. Zehra M., Zubairi W., Hasan A., Butt H., Ramzan A., Azam M. et al. Oxygen Generating Polymeric Nano Fibers That Stimulate Angiogenesis and Show Efficient Wound Healing in a Diabetic Wound Model. Int. J. Nanomed.. 2020 doi:10.2147/IJN.S248911 PubMed
58. Lee C.-H., Chang S.-H., Chen W.-J., Hung K.-C., Lin Y.-H., Liu S.-J. et al. Augmentation of diabetic wound healing and enhancement of collagen content using nanofibrous glucophage-loaded collagen/PLGA scaffold membranes. J. Colloid Interface Sci.. 2015 doi:10.1016/j.jcis.2014.10.028 PubMed
59. Zheng Z., Liu Y., Huang W., Mo Y., Lan Y., Guo R. et al. Neurotensin-loaded PLGA/CNC composite nanofiber membranes accelerate diabetic wound healing. Artif. Cells, Nanomed. Biotechnol.. 2018 doi:10.1080/21691401.2018.1460372 PubMed
60. Liu F., Li X., Wang L., Yan X., Ma D., Liu Z. et al. Sesamol incorporated cellulose acetate-zein composite nanofiber membrane: An efficient strategy to accelerate diabetic wound healing. Int. J. Biol. Macromol.. 2020 doi:10.1016/j.ijbiomac.2020.01.277 PubMed
61. Lee C.-H., Hsieh M.-J., Chang S.-H., Lin Y.-H., Liu S.-J., Lin T.-Y. et al. Enhancement of Diabetic Wound Repair Using Biodegradable Nanofibrous Metformin-Eluting Membranes: In Vitro and in Vivo. ACS Appl. Mater. Interfaces. 2014 doi:10.1021/am405329g PubMed
62. Ren X., Han Y., Wang J., Jiang Y., Yi Z., Xu H. et al. An aligned porous electrospun fibrous membrane with controlled drug delivery—An efficient strategy to accelerate diabetic wound healing with improved angiogenesis. Acta Biomater.. 2018 doi:10.1016/j.actbio.2018.02.010 PubMed
63. Lobmann R., Pittasch D., Mühlen I., Lehnert H.. Autologous human keratinocytes cultured on membranes composed of benzyl ester of hyaluronic acid for grafting in nonhealing diabetic foot lesions. J. Diabetes Its Complicat.. 2003 doi:10.1016/S1056-8727(02)00218-0 PubMed
64. Augustine R., Hasan A., Patan N.K., Dalvi Y.B., Varghese R., Antony A. et al. Cerium Oxide Nanoparticle Incorporated Electrospun Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Membranes for Diabetic Wound Healing Applications. ACS Biomater. Sci. Eng.. 2020 doi:10.1021/acsbiomaterials.8b01352 PubMed
65. Augustine R., Zahid A.A., Hasan A., Wang M., Webster T.J.. CTGF Loaded Electrospun Dual Porous Core-Shell Membrane for Diabetic Wound Healing. Int. J. Nanomed.. 2019 doi:10.2147/IJN.S224047 PubMed
66. Arantes V.T., Faraco A.A., Ferreira F.B., Oliveira C.A., Martins-Santos E., Cassini-Vieira P. et al. Retinoic acid-loaded solid lipid nanoparticles surrounded by chitosan film support diabetic wound healing in in vivo study. Colloids Surf. B Biointerfaces. 2020 doi:10.1016/j.colsurfb.2019.110749 PubMed
67. Arul V., Kartha R., Jayakumar R.. A therapeutic approach for diabetic wound healing using biotinylated GHK incorporated collagen matrices. Life Sci.. 2007 doi:10.1016/j.lfs.2006.09.018 PubMed
68. Inpanya P., Faikrua A., Ounaroon A., Sittichokechaiwut A., Viyoch J.. Effects of the blended fibroin/aloe gel film on wound healing in streptozotocin-induced diabetic rats. Biomed. Mater.. 2012 doi:10.1088/1748-6041/7/3/035008 PubMed
69. Kim D.W., Kim K.S., Seo Y.G., Lee B.-J., Park Y.J., Youn Y.S. et al. Novel sodium fusidate-loaded film-forming hydrogel with easy application and excellent wound healing. Int. J. Pharm.. 2015 doi:10.1016/j.ijpharm.2015.08.082 PubMed
70. Mizuno K., Yamamura K., Yano K., Osada T., Saeki S., Takimoto N. et al. Effect of chitosan film containing basic fibroblast growth factor on wound healing in genetically diabetic mice. J. Biomed. Mater. Res.. 2003 doi:10.1002/jbm.a.10396 PubMed
71. Song S.H., Kim J.E., Koh E.K., Sung J.E., Lee H.A., Yun W.B. et al. Selenium-loaded cellulose film derived from Styela clava tunic accelerates the healing process of cutaneous wounds in streptozotocin-induced diabetic Sprague–Dawley rats. J. Dermatol. Treat.. 2018 doi:10.1080/09546634.2018.1425357 PubMed
72. Tan W.S., Arulselvan P., Ng S.-F., Taib C.N.M., Sarian M.N., Fakurazi S.. Improvement of diabetic wound healing by topical application of Vicenin-2 hydrocolloid film on Sprague Dawley rats. BMC Complement. Altern. Med.. 2019 doi:10.1186/s12906-018-2427-y PubMed
73. Tong W.Y., bin Abdullah A.Y.K., binti Rozman N.A.S., bin Wahid M.I.A., Hossain M., Ring L.C. et al. Antimicrobial wound dressing film utilizing cellulose nanocrystal as drug delivery system for curcumin. Cellulose. 2018 doi:10.1007/s10570-017-1562-9
74. Voss G.T., Gularte M.S., Vogt A.G., Giongo J.L., Vaucher R.A., Echenique J.V. et al. Polysaccharide-based film loaded with vitamin C and propolis: A promising device to accelerate diabetic wound healing. Int. J. Pharm.. 2018 doi:10.1016/j.ijpharm.2018.10.009 PubMed
75. Wu Y.-Y., Jiao Y.-P., Xiao L.-L., Li M.-M., Liu H.-W., Li S.-H. et al. Experimental Study on Effects of Adipose-Derived Stem Cell–Seeded Silk Fibroin Chitosan Film on Wound Healing of a Diabetic Rat Model. Ann. Plast. Surg.. 2018 doi:10.1097/SAP.0000000000001355 PubMed
76. da Silva L.P., Santos T.C., Rodrigues D.B., Pirraco R.P., Cerqueira M.T., Reis R.L. et al. Stem Cell-Containing Hyaluronic Acid-Based Spongy Hydrogels for Integrated Diabetic Wound Healing. J. Investig. Dermatol.. 2017 doi:10.1016/j.jid.2017.02.976 PubMed
77. Lai J.C.-Y., Lai H.-Y., Rao N.K., Ng S.-F.. Treatment for diabetic ulcer wounds using a fern tannin optimized hydrogel formulation with antibacterial and antioxidative properties. J. Ethnopharmacol.. 2016 doi:10.1016/j.jep.2016.05.032 PubMed
78. Li M., Ke Q.-F., Tao S.-C., Guo S.-C., Rui B.-Y., Guo Y.-P.. Fabrication of hydroxyapatite/chitosan composite hydrogels loaded with exosomes derived from miR-126-3p overexpressed synovial mesenchymal stem cells for diabetic chronic wound healing. J. Mater. Chem. B. 2016 doi:10.1039/C6TB01560C PubMed
79. Masood N., Ahmed R., Tariq M., Ahmed Z., Masoud M.S., Ali I. et al. Silver nanoparticle impregnated chitosan-PEG hydrogel enhances wound healing in diabetes induced rabbits. Int. J. Pharm.. 2019 doi:10.1016/j.ijpharm.2019.01.019 PubMed
80. Shi G., Chen W., Zhang Y., Dai X., Zhang X., Wu Z.. An Antifouling Hydrogel Containing Silver Nanoparticles for Modulating the Therapeutic Immune Response in Chronic Wound Healing. Langmuir. 2019 doi:10.1021/acs.langmuir.8b01834 PubMed
81. Thangavel P., Ramachandran B., Chakraborty S., Kannan R., Lonchin S., Muthuvijayan V.. Accelerated Healing of Diabetic Wounds Treated with L-Glutamic acid Loaded Hydrogels Through Enhanced Collagen Deposition and Angiogenesis: An In Vivo Study. Sci. Rep.. 2017 doi:10.1038/s41598-017-10882-1 PubMed
82. Zhang L., Ma Y., Pan X., Chen S., Zhuang H., Wang S.. A composite hydrogel of chitosan/heparin/poly (γ-glutamic acid) loaded with superoxide dismutase for wound healing. Carbohydr. Polym.. 2018 doi:10.1016/j.carbpol.2017.10.036 PubMed
83. Choi H.J., Thambi T., Yang Y.H., Bang S.I., Kim B.S., Pyun D.G. et al. AgNP and rhEGF-incorporating synergistic polyurethane foam as a dressing material for scar-free healing of diabetic wounds. RSC Adv.. 2017 doi:10.1039/C6RA27322J
84. Pyun D.G., Choi H.J., Yoon H.S., Thambi T., Lee D.S.. Polyurethane foam containing rhEGF as a dressing material for healing diabetic wounds: Synthesis, characterization, in vitro and in vivo studies. Colloids Surfaces B Biointerfaces. 2015 doi:10.1016/j.colsurfb.2015.08.029 PubMed
85. Atia N.M., Hazzah H.A., Gaafar P.M., Abdallah O.Y.. Diosmin Nanocrystal–Loaded Wafers for Treatment of Diabetic Ulcer: In Vitro and In Vivo Evaluation. J. Pharm. Sci.. 2019 doi:10.1016/j.xphs.2018.12.019 PubMed
86. Anisha B., Biswas R., Chennazhi K., Jayakumar R.. Chitosan–hyaluronic acid/nano silver composite sponges for drug resistant bacteria infected diabetic wounds. Int. J. Biol. Macromol.. 2013 doi:10.1016/j.ijbiomac.2013.09.011 PubMed
87. Lipsky B.A., Kuss M., Edmonds M., Reyzelman A., Sigal F.. Topical Application of a Gentamicin-Collagen Sponge Combined with Systemic Antibiotic Therapy for the Treatment of Diabetic Foot Infections of Moderate Severity. J. Am. Podiatr. Med. Assoc.. 2012 doi:10.7547/1020223 PubMed
88. Mohandas A., Anisha B., Chennazhi K., Jayakumar R.. Chitosan–hyaluronic acid/VEGF loaded fibrin nanoparticles composite sponges for enhancing angiogenesis in wounds. Colloids Surfaces B Biointerfaces. 2015 doi:10.1016/j.colsurfb.2015.01.024 PubMed
89. Shi Q., Qian Z., Liu D., Sun J., Wang X., Liu H. et al. GMSC-Derived Exosomes Combined with a Chitosan/Silk Hydrogel Sponge Accelerates Wound Healing in a Diabetic Rat Skin Defect Model. Front. Physiol.. 2017 doi:10.3389/fphys.2017.00904 PubMed
90. Wang W., Lin S., Xiao Y., Huang Y., Tan Y., Cai L. et al. Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats. Life Sci.. 2008 doi:10.1016/j.lfs.2007.11.009 PubMed
91. Xia G., Zhai D., Sun Y., Hou L., Guo X., Wang L. et al. Preparation of a novel asymmetric wettable chitosan-based sponge and its role in promoting chronic wound healing. Carbohydr. Polym.. 2020 doi:10.1016/j.carbpol.2019.115296 PubMed
92. Kondo S., Niiyama H., Yu A., Kuroyanagi Y.. Evaluation of a Wound Dressing Composed of Hyaluronic Acid and Collagen Sponge Containing Epidermal Growth Factor in Diabetic Mice. J. Biomater. Sci. Polym. Ed.. 2012 doi:10.1163/092050611X597799 PubMed
93. Thattaruparambil Raveendran N., Mohandas A., Ramachandran Menon R., Somasekharan Menon A., Biswas R., Jayakumar R.. Ciprofloxacin- and Fluconazole-Containing Fibrin-Nanoparticle-Incorporated Chitosan Bandages for the Treatment of Polymicrobial Wound Infections. ACS Appl. Bio Mater.. 2019 doi:10.1021/acsabm.8b00585 PubMed
94. Mohanty C., Pradhan J.. A human epidermal growth factor-curcumin bandage bioconjugate loaded with mesenchymal stem cell for in vivo diabetic wound healing. Mater. Sci. Eng. C. 2020 doi:10.1016/j.msec.2020.110751 PubMed
95. Kumar P.T.S., Lakshmanan V.-K., Anilkumar T., Ramya C., Reshmi P., Unnikrishnan A. et al. Flexible and Microporous Chitosan Hydrogel/Nano ZnO Composite Bandages for Wound Dressing: In Vitro and In Vivo Evaluation. ACS Appl. Mater. Interfaces. 2012 doi:10.1021/am300292v PubMed
96. Kahan V., Andersen M., Tomimori J., Tufik S.. Stress, immunity and skin collagen integrity: Evidence from animal models and clinical conditions. Brain Behav. Immun.. 2009 doi:10.1016/j.bbi.2009.06.002 PubMed
97. Shoulders M.D., Raines R.T.. Collagen Structure and Stability. Annu. Rev. Biochem.. 2009 doi:10.1146/annurev.biochem.77.032207.120833 PubMed
98. Naomi R., Fauzi M.B.. Cellulose/Collagen Dressings for Diabetic Foot Ulcer: A Review. Pharmaceutics. 2020 doi:10.3390/pharmaceutics12090881 PubMed
99. Davison-Kotler E., Marshall W.S., García-Gareta E.. Sources of Collagen for Biomaterials in Skin Wound Healing. Bioengineering. 2019 doi:10.3390/bioengineering6030056 PubMed
100. Ruszczak Z.. Effect of collagen matrices on dermal wound healing. Adv. Drug Deliv. Rev.. 2003 doi:10.1016/j.addr.2003.08.003 PubMed
101. Chen F.-M., Liu X.. Advancing biomaterials of human origin for tissue engineering. Prog. Polym. Sci.. 2016 doi:10.1016/j.progpolymsci.2015.02.004 PubMed
102. Sorushanova A., Delgado L.M., Wu Z., Shologu N., Kshirsagar A., Raghunath R. et al. The Collagen Suprafamily: From Biosynthesis to Advanced Biomaterial Development. Adv. Mater.. 2019 doi:10.1002/adma.201801651 PubMed
103. Ricard-Blum S.. The Collagen Family. Cold Spring Harb. Perspect. Biol.. 2011 doi:10.1101/cshperspect.a004978 PubMed
104. Parenteau-Bareil R., Gauvin R., Berthod F.. Collagen-Based Biomaterials for Tissue Engineering Applications. Materials. 2010 doi:10.3390/ma3031863
105. Brodsky B., Eikenberry E.F.. [5] Characterization of Fibrous Forms of Collagen. Methods in Enzymology. 1982 doi:10.1016/0076-6879(82)82062-4 PubMed
106. Haut R.C.. Age-Dependent Influence of Strain Rate on the Tensile Failure of Rat-Tail Tendon. J. Biomech. Eng.. 1983 doi:10.1115/1.3138422 PubMed
107. Ferraro V., Gaillard-Martinie B., Sayd T., Chambon C., Anton M., Santé-Lhoutellier V.. Collagen type I from bovine bone. Effect of animal age, bone anatomy and drying methodology on extraction yield, self-assembly, thermal behaviour and electrokinetic potential. Int. J. Biol. Macromol.. 2017 doi:10.1016/j.ijbiomac.2016.12.068 PubMed
108. Asghar A., Henrickson R.L.. Chemical, Biochemical, Functional, and Nutritional Characteristics of Collagen in Food Systems. Advances in Food Research. 1982 doi:10.1016/s0065-2628(08)60113-5 PubMed
109. Nehrer S.. Chondrocyte-seeded collagen matrices implanted in a chondral defect in a canine model. Biomaterials. 1998 doi:10.1016/S0142-9612(98)00143-4 PubMed
110. Geesin J.C., Brown L.J., Liu Z., Berg R.A.. Development of a Skin Model Based on Insoluble Fibrillar Collagen. J. Biomed. Mater. Res.. 1996 doi:10.1002/(SICI)1097-4636(199621)33:1<1::AID-JBM1>3.0.CO;2-W PubMed
111. Doillon C.J., Silver F.H., Berg R.A.. Fibroblast growth on a porous collagen sponge containing hyaluronic acid and fibronectin. Biomaterials. 1987 doi:10.1016/0142-9612(87)90063-9 PubMed
112. Rovira A., Amedee J., Bareille R., Rabaud M.. Colonization of a calcium phosphate/ elastin-solubilized peptide-collagen composite material by human osteoblasts. Biomaterials. 1996 doi:10.1016/0142-9612(96)89779-1 PubMed
113. Leipziger L.S., Glushko V., DiBernardo B., Shafaie F., Noble J., Nichols J. et al. Dermal wound repair: Role of collagen matrix implants and synthetic polymer dressings. J. Am. Acad. Dermatol.. 1985 doi:10.1016/S0190-9622(85)80004-9 PubMed
114. McPherson J.M., Sawamura S., Armstrong R.. An examination of the biologic response to injectable, glutaraldehyde cross-linked collagen implants. J. Biomed. Mater. Res.. 1986 doi:10.1002/jbm.820200109 PubMed
115. Gerrits L., Hammink R., Kouwer P.H.J.. Semiflexible polymer scaffolds: An overview of conjugation strategies. Polym. Chem.. 2021 doi:10.1039/D0PY01662D
116. Chattopadhyay S., Raines R.T.. Collagen-based biomaterials for wound healing. Biopolymers. 2014 doi:10.1002/bip.22486 PubMed
117. Zaulyanov L., Kirsner R.S.. A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers. Clin. Interv. Aging. 2007 doi:10.2147/ciia.2007.2.1.93 PubMed
118. Rennert R.C., Rodrigues M., Wong V.W., Duscher D., Hu M., Maan Z. et al. Biological therapies for the treatment of cutaneous wounds: Phase III and launched therapies. Expert Opin. Biol. Ther.. 2013 doi:10.1517/14712598.2013.842972 PubMed
119. Munish T., Ramneesh G., Sanjeev S., Jasdeep S., Jaspal S., Nikhil G.. Comparative Study of Collagen Based Dressing and Standard Dressing in Diabetic Foot Ulcer. J. Evol. Med. Dent. Sci.. 2015 doi:10.14260/jemds/2015/521
120. Lee D.S., Lee Y.N., Han S.K., Namgoong S.. Effect of Collagen Dressing on Diabetic Wound Healing-A Pilot Study. J. Korean Wound Manag. Soc.. 2015
121. Hauck S., Zager P., Halfter N., Wandel E., Torregrossa M., Kakpenova A. et al. Collagen/hyaluronan based hydrogels releasing sulfated hyaluronan improve dermal wound healing in diabetic mice via reducing inflammatory macrophage activity. Bioact. Mater.. 2021 doi:10.1016/j.bioactmat.2021.04.026 PubMed
122. Shagdarova B., Konovalova M., Zhuikova Y., Lunkov A., Zhuikov V., Khaydapova D. et al. Collagen/Chitosan Gels Cross-Linked with Genipin for Wound Healing in Mice with Induced Diabetes. Materials. 2021 doi:10.3390/ma15010015 PubMed
123. Michelacci Y.M.. Collagens and proteoglycans of the corneal extracellular matrix. Braz. J. Med. Biol. Res.. 2003 doi:10.1590/S0100-879X2003000800009 PubMed
124. Duconseille A., Astruc T., Quintana N., Meersman F., Sante-Lhoutellier V.. Gelatin structure and composition linked to hard capsule dissolution: A review. Food Hydrocoll.. 2015 doi:10.1016/j.foodhyd.2014.06.006
125. Rodríguez-Rodríguez R., Espinosa-Andrews H., Velasquillo-Martínez C., García-Carvajal Z.Y.. Composite Hydrogels based on gelatin, chitosan and polyvinyl alcohol to biomedical applications: A review. Int. J. Polym. Mater. Polym. Biomater.. 2020 doi:10.1080/00914037.2019.1581780
126. Samadian H., Zamiri S., Ehterami A., Farzamfar S., Vaez A., Khastar H. et al. Electrospun cellulose acetate/gelatin nanofibrous wound dressing containing berberine for diabetic foot ulcer healing: In vitro and in vivo studies. Sci. Rep.. 2020 doi:10.1038/s41598-020-65268-7 PubMed
127. Yu H., Gong W., Mei J., Qin L., Piao Z., You D. et al. The efficacy of a paeoniflorin-sodium alginate-gelatin skin scaffold for the treatment of diabetic wound: An in vivo study in a rat model. Biomed. Pharmacother.. 2022 doi:10.1016/j.biopha.2022.113165 PubMed
128. Sadeghi A., Zare-Gachi M., Najjar-Asl M., Rajabi S., Fatemi M.J., Forghani S.F. et al. Hybrid gelatin-sulfated alginate scaffolds as dermal substitutes can dramatically accelerate healing of full-thickness diabetic wounds. Carbohydr. Polym.. 2023 doi:10.1016/j.carbpol.2022.120404 PubMed
129. Zheng Y., Yuan W., Liu H., Huang S., Bian L., Guo R.. Injectable supramolecular gelatin hydrogel loading of resveratrol and histatin-1 for burn wound therapy. Biomater. Sci.. 2020 doi:10.1039/D0BM00391C PubMed
130. Wolberg A.S.. Thrombin generation and fibrin clot structure. Blood Rev.. 2007 doi:10.1016/j.blre.2006.11.001 PubMed
131. Uzunalli G.. Nanomaterials for Wound Healing. Nanomaterials for Regenerative Medicine. 2019
132. Heher P., Mühleder S., Mittermayr R., Redl H., Slezak P.. Fibrin-based delivery strategies for acute and chronic wound healing. Adv. Drug Deliv. Rev.. 2018 doi:10.1016/j.addr.2017.12.007 PubMed
133. Losi P., Briganti E., Errico C., Lisella A., Sanguinetti E., Chiellini F. et al. Fibrin-based scaffold incorporating VEGF- and bFGF-loaded nanoparticles stimulates wound healing in diabetic mice. Acta Biomater.. 2013 doi:10.1016/j.actbio.2013.04.019 PubMed
134. Al Kayal T., Losi P., Pierozzi S., Soldani G.. A New Method for Fibrin-Based Electrospun/Sprayed Scaffold Fabrication. Sci. Rep.. 2020 doi:10.1038/s41598-020-61933-z PubMed
135. Geer D.J., Swartz D.D., Andreadis S.T.. Fibrin Promotes Migration in a Three-Dimensional in Vitro Model of Wound Regeneration. Tissue Eng.. 2002 doi:10.1089/10763270260424141 PubMed
136. Falanga V., Iwamoto S., Chartier M., Yufit T., Butmarc J., Kouttab N. et al. Autologous Bone Marrow–Derived Cultured Mesenchymal Stem Cells Delivered in a Fibrin Spray Accelerate Healing in Murine and Human Cutaneous Wounds. Tissue Eng.. 2007 doi:10.1089/ten.2006.0278 PubMed
137. Crisci A., Marotta G., Licito A., Serra E., Benincasa G., Crisci M.. Use of Leukocyte Platelet (L-PRF) Rich Fibrin in Diabetic Foot Ulcer with Osteomyelitis (Three Clinical Cases Report). Diseases. 2018 doi:10.3390/diseases6020030 PubMed
138. Losi P., Al Kayal T., Buscemi M., Foffa I., Cavallo A., Soldani G.. Bilayered Fibrin-Based Electrospun-Sprayed Scaffold Loaded with Platelet Lysate Enhances Wound Healing in a Diabetic Mouse Model. Nanomaterials. 2020 doi:10.3390/nano10112128 PubMed
139. Chouhan D., Mandal B.B.. Silk biomaterials in wound healing and skin regeneration therapeutics: From bench to bedside. Acta Biomater.. 2020 doi:10.1016/j.actbio.2019.11.050 PubMed
140. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J. et al. Silk-based biomaterials. Biomaterials. 2003 doi:10.1016/S0142-9612(02)00353-8 PubMed
141. Park Y.R., Sultan T., Park H.J., Lee J.M., Ju H.W., Lee O.J. et al. NF-κB signaling is key in the wound healing processes of silk fibroin. Acta Biomater.. 2018 doi:10.1016/j.actbio.2017.12.006 PubMed
142. Capar G., Aygun S.S., Gecit M.R.. Separation of sericin from fatty acids towards its recovery from silk degumming wastewaters. J. Membr. Sci.. 2009 doi:10.1016/j.memsci.2009.06.039
143. Tariq M., Tahir H.M., Butt S.A., Ali S., Ahmad A.B., Raza C. et al. Silk derived formulations for accelerated wound healing in diabetic mice. Peerj. 2021 doi:10.7717/peerj.10232 PubMed
144. Sultan M.T., Lee O.J., Kim S.H., Ju H.W., Park C.H.. Silk Fibroin in Wound Healing Process. Novel Biomaterials for Regenerative Medicine. 2018 doi:10.1007/978-981-13-0947-2_7 PubMed
145. Liu J., Yan L., Yang W., Lan Y., Zhu Q., Xu H. et al. Controlled-release neurotensin-loaded silk fibroin dressings improve wound healing in diabetic rat model. Bioact. Mater.. 2019 doi:10.1016/j.bioactmat.2019.03.001 PubMed
146. Guan G., Zhang Q., Jiang Z., Liu J., Wan J., Jin P. et al. Multifunctional Silk Fibroin Methacryloyl Microneedle for Diabetic Wound Healing. Small. 2022 doi:10.1002/smll.202203064 PubMed
147. Xu X., Wang X., Qin C., Khan A.U.R., Zhang W., Mo X.. Silk fibroin/poly-(L-lactide-co-caprolactone) nanofiber scaffolds loaded with Huangbai Liniment to accelerate diabetic wound healing. Colloids Surfaces B Biointerfaces. 2021 doi:10.1016/j.colsurfb.2021.111557 PubMed
148. Baptista-Silva S., Bernardes B.G., Borges S., Rodrigues I., Fernandes R., Gomes-Guerreiro S. et al. Exploring Silk Sericin for Diabetic Wounds: An In Situ-Forming Hydrogel to Protect against Oxidative Stress and Improve Tissue Healing and Regeneration. Biomolecules. 2022 doi:10.3390/biom12060801 PubMed
149. El-Samad L.M., Hassan M.A., Basha A.A., El-Ashram S., Radwan E.H., Aziz K.K.A. et al. Carboxymethyl cellulose/sericin-based hydrogels with intrinsic antibacterial, antioxidant, and anti-inflammatory properties promote re-epithelization of diabetic wounds in rats. Int. J. Pharm.. 2022 doi:10.1016/j.ijpharm.2022.122328 PubMed
150. Alven S., Nqoro X., Aderibigbe B.A.. Polymer-Based Materials Loaded with Curcumin for Wound Healing Applications. Polymers. 2020 doi:10.3390/polym12102286 PubMed
151. Mir M., Ali M.N., Barakullah A., Gulzar A., Arshad M., Fatima S. et al. Synthetic polymeric biomaterials for wound healing: A review. Prog. Biomater.. 2018 doi:10.1007/s40204-018-0083-4 PubMed
152. Mondal D., Griffith M., Venkatraman S.S.. Polycaprolactone-based biomaterials for tissue engineering and drug delivery: Current scenario and challenges. Int. J. Polym. Mater. Polym. Biomater.. 2016 doi:10.1080/00914037.2015.1103241
153. Huang X., Wang Q., Mao R., Wang Z., Shen S.G., Mou J. et al. Two-dimensional nanovermiculite and polycaprolactone electrospun fibers composite scaffolds promoting diabetic wound healing. J. Nanobiotechnology. 2022 doi:10.1186/s12951-022-01556-w PubMed
154. Lv F., Wang J., Xu P., Han Y., Ma H., Xu H. et al. A conducive bioceramic/polymer composite biomaterial for diabetic wound healing. Acta Biomater.. 2017 doi:10.1016/j.actbio.2017.07.020 PubMed
155. Awasthi A., Gulati M., Kumar B., Kaur J., Vishwas S., Khursheed R. et al. Recent Progress in Development of Dressings Used for Diabetic Wounds with Special Emphasis on Scaffolds. BioMed Res. Int.. 2022 doi:10.1155/2022/1659338 PubMed
156. Huang X., Guan N., Li Q.. A Marine-Derived Anti-Inflammatory Scaffold for Accelerating Skin Repair in Diabetic Mice. Mar. Drugs. 2021 doi:10.3390/md19090496 PubMed
157. Lin W.-C., Tang C.-M.. Evaluation of Polyvinyl Alcohol/Cobalt Substituted Hydroxyapatite Nanocomposite as a Potential Wound Dressing for Diabetic Foot Ulcers. Int. J. Mol. Sci.. 2020 doi:10.3390/ijms21228831 PubMed
158. Zhu H., Xu J., Zhao M., Luo H., Lin M., Luo Y. et al. Adhesive, injectable, and ROS-responsive hybrid polyvinyl alcohol (PVA) hydrogel co-delivers metformin and fibroblast growth factor 21 (FGF21) for enhanced diabetic wound repair. Front. Bioeng. Biotechnol.. 2022 doi:10.3389/fbioe.2022.968078 PubMed
159. Wang Z., Gao S., Zhang W., Gong H., Xu K., Luo C. et al. Polyvinyl alcohol/chitosan composite hydrogels with sustained release of traditional Tibetan medicine for promoting chronic diabetic wound healing. Biomater. Sci.. 2021 doi:10.1039/D1BM00346A PubMed
160. Zare M., Bigham A., Zare M., Luo H., Ghomi E.R., Ramakrishna S.. pHEMA: An Overview for Biomedical Applications. Int. J. Mol. Sci.. 2021 doi:10.3390/ijms22126376 PubMed
161. Khazaeli P., Alaei M., Khaksarihadad M., Ranjbar M.. Preparation of PLA/chitosan nanoscaffolds containing cod liver oil and experimental diabetic wound healing in male rats study. J. Nanobiotechnology. 2020 doi:10.1186/s12951-020-00737-9 PubMed
162. Zha S., Utomo Y.K.S., Yang L., Liang G., Liu W.. Mechanic-Driven Biodegradable Polyglycolic Acid/Silk Fibroin Nanofibrous Scaffolds Containing Deferoxamine Accelerate Diabetic Wound Healing. Pharmaceutics. 2022 doi:10.3390/pharmaceutics14030601 PubMed